Report Detail
Drug Eluting Stent Market By Polymer Type (Bio-absorbable, Durable), By Material Type (Stainless steel, Cobalt chromium), By End User (Ambulatory surgical centers, Clinics, Hospitals), By Application (Coronary artery disease, Peripheral artery disease), Industry Trends, Estimation & Forecast, 2017 - 2025
- RnM3857410 |
- 23 December, 2019 |
- Global |
- 145 Pages |
- Esticast Research & Consulting |
- Medical Devices & Consumables
“Drug Eluting Stent Market” 2018-2026 report is a professional study on the current state of the market that focuses on the major drivers, challenges, opportunities for the leading players. The research report also offers a granular analysis of various definitions, and classification of the industry, applications of the industry, regional breakdown, opportunities, challenges, and chain structure.
About Drug Eluting Stent Market
Drug eluting stent is a small mesh tube that is inserted into a diseased peripheral or coronary artery to prevent the blockage occurring in the artery. The stent releases a drug that blocks cell proliferation by opening the artery and improving blood circulation. The sudden rise in prevalence of cardiovascular diseases across the globe, is fueling the demand for drug eluting stents. According to WHO, 17.7 million people die every year because of cardiovascular diseases, i.e. % of all global deaths. Furthermore, risk associated with drug eluting stent such as stent thrombosis, disturbance of regrowth of endothelial tissues, and long term use of medication is challenging the growth of drug eluting stent market.
Market Summary:
The Drug Eluting Stent market is a comprehensive report which offers a meticulous overview of the market share, size, trends, demand, product analysis, application analysis, regional outlook, competitive strategies, forecasts, and strategies impacting the Drug Eluting Stent Industry. The report includes a detailed analysis of the market competitive landscape, with the help of detailed business profiles, SWOT analysis, project feasibility analysis, and several other details about the key companies operating in the market.
The study on the worldwide Drug Eluting Stent market strives to offer substantial and profound insights into the current market scenario and the developing growth dynamics. Moreover, the report also provides the market players along with the new contenders a complete view of the market landscape. The inclusive research will enable the well-established as well as the entry-level players to establish their business strategies and accomplish their short-term and long-term goals.
Scope and Segmentation of the Report
The segment analysis is one of the significant sections of this report. Our expert analyst has categorized the market into product type, application/end-user, and geography. All the segments are analyzed based on their market share, growth rate, and growth potential. In the geographical classification, the report highlights the regional markets having high growth potential. This thorough evaluation of the segments would help the players to focus on revenue-generating areas of the Drug Eluting Stent market.
Based on Type
By Polymer Type
Bio-absorbable polymer
Durable polymer
Based on Application
Coronary artery disease
Peripheral artery disease
Regional Analysis
Our analysts are experts in covering all types of geographical markets from developing to mature ones. You can expect a comprehensive research analysis of key regional and country-level markets such as Europe, North America, South America, Asia-Pacific, and the Middle East & Africa. With accurate statistical patterns and regional classification, our domain experts provide you one of the most detailed and easily understandable regional analyses of the Drug Eluting Stent market.
Competitive Landscape:
The research report also studied the key players operating in the Drug Eluting Stent market. It has evaluated and explained the research & development stages of these companies, their financial performances, and their expansion plans for the coming years. Moreover, the research report also includes the list of planned initiatives that clearly explain the accomplishments of the companies in the recent past.
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products, etc.):
Abbott Laboratories
Meril Life Sciences Pvt.
Boston Scientific Corporation
Medtronic plc.
Biosensors International Group
Ltd.
BIOTRONIK SE & Co. KG
B. Braun Melsungen AG
MicroPort Scientific Corporation
Ltd.
TERUMO CORPORATION
Translumina GmbH
Research Methodology
The research methodology of the market is based on both primary as well as secondary research data sources. It compels different factors affecting the Drug Eluting Stent industry such as historical data and market trends, different policies of the government, market environment, market risk factors, market restraints, technological advancements, forthcoming innovations, and obstacles in the industry.
The content of the study subjects includes a total of 8 chapters:
Chapter 1, describe the Drug Eluting Stent market report’s – executive summary, market definition, and market scope. Moreover, the report helps in picking up the crucial information about the said market.
Chapter 2, defines the Research Methodology including primary research, assumptions & exclusions, and secondary data sources. The report follows the simultaneous top-down and bottom approach to provide you the accurate market sizing.
Chapter 3, explains the report segmentation & scope, key market trends (drivers, restraints, and opportunities), along with Porter’s five forces analysis and market share analysis
Chapter 4: It helps in understanding the key product segments and their future of the Drug Eluting Stent Market. It provides strategic recommendations in key business segments based on the market estimations.
Chapters 5, and 6 to segment the sales by type and application/end-user, with sales market share and growth rate by type, application/end-user, from 2018 to 2016. Our team of Analysts and experts dedicatedly put their effort to provide you the best possible and accurate segmentation data and analysis.
Chapter 7, describes the regional segmentation based on the country level for the forecast period 2018 – 2026. The research report not only provide the market data of the five geographies but also provide the qualitative as well we qualitative information on country level bifurcation.
Chapter 8, to profile the top manufacturers of Drug Eluting Stent, with price, sales, revenue and market share of Drug Eluting Stent in 2016, 2017, and 2018. Players are expected to sign acquisition and collaboration deals to expand their products and services portfolio. Such strategic agreements could help them to improve their client base in other countries and gain a competitive advantage
CHAPTER 1. INTRODUCTION
- 1.1. RESEARCH METHODOLOGY
- 1.1.1. ERC desk research
- 1.1.2. ERC data synthesis
- 1.1.3. Data validation and market feedback
- 1.1.4. ERC data sources
CHAPTER 2. DRUG ELUTING STENT MARKET OVERVIEW
- 2.1. DRUG ELUTING STENT MARKET INTRODUCTION
- 2.2. GLOBAL DRUG ELUTING STENT MARKET PRODUCTION AND GROWTH RATE, 2017-2025
- 2.2.1. Global Drug Eluting Stent Production (VOLUME) and Growth Rate (%), (2017-2025)
- 2.3. GLOBAL DRUG ELUTING STENT MARKET CAPACITY AND GROWTH RATE, 2017-2025
- 2.3.1. Global Drug Eluting Stent Capacity (VOLUME) and Growth Rate (%), (2017-2025)
- 2.4. GLOBAL DRUG ELUTING STENT MARKET REVENUE AND GROWTH RATE, 2017-2025
- 2.4.1. Global Drug Eluting Stent Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
- 2.5. GLOBAL DRUG ELUTING STENT MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
- 2.5.1. Global Drug Eluting Stent Consumption (VOLUME) and Growth Rate (%), (2017-2025)
CHAPTER 3. GLOBAL DRUG ELUTING STENT MARKET BY POLYMER TYPE, 2017-2025
- 3.1. BIO-ABSORBABLE POLYMER
- 3.2. DURABLE POLYMER
- 3.3. GLOBAL DRUG ELUTING STENT MARKET REVENUE BY POLYMER TYPE, 2017-2025
- 3.3.1. Global Drug Eluting Stent Market Revenue (Million USD) and Share (%) By Polymer Type, 2017-2025
- 3.3.2. Bio-absorbable polymer Market Revenue and Growth Rate, 2017-2025
- 3.3.3. Durable polymer Market Revenue and Growth Rate, 2017-2025
- 3.4. GLOBAL DRUG ELUTING STENT MARKET PRODUCTION BY POLYMER TYPE, 2017-2025
- 3.4.1. Global Drug Eluting Stent Market Production (Volume) and Share (%) By Polymer Type, 2017-2025
- 3.4.2. Bio-absorbable polymer Market Production and Growth Rate, 2017-2025
- 3.4.3. Durable polymer Market Production and Growth Rate, 2017-2025
Note: Similar information coverage has been provided for material type segment.
CHAPTER 4. GLOBAL DRUG ELUTING STENT MARKET BY APPLICATION, 2017-2025
- 4.1. CORONARY ARTERY DISEASE
- 4.2. PERIPHERAL ARTERY DISEASE
- 4.3. GLOBAL DRUG ELUTING STENT MARKET REVENUE BY APPLICATION, 2017-2025
- 4.3.1. Global Drug Eluting Stent Market Revenue (Million USD) and Share (%) By Application, 2017-2025
- 4.3.2. Coronary artery disease Market Revenue and Growth Rate, 2017-2025
- 4.3.3. Peripheral artery disease Market Revenue and Growth Rate, 2017-2025
- 4.4. GLOBAL DRUG ELUTING STENT MARKET CONSUMPTION BY APPLICATION, 2017-2025
- 4.4.1. Global Drug Eluting Stent Market Consumption (Volume) and share (%) By Application, 2017-2025
- 4.4.2. Coronary artery disease Market Consumption and Growth Rate, 2017-2025
- 4.4.3. Peripheral artery disease Market Consumption and Growth Rate, 2017-2025
Note: Similar information coverage has been provided for end user segment.
CHAPTER 5. GLOBAL DRUG ELUTING STENT MARKET BY REGION, 2017-2025
- 5.1. NORTH AMERICA
- 5.1.1. U.S.
- 5.1.2. Canada
- 5.1.3. Mexico
- 5.2. EUROPE
- 5.2.1. U.K.
- 5.2.2. France
- 5.2.3. Germany
- 5.2.4. Italy
- 5.2.5. Spain
- 5.2.6. Rest of Europe
- 5.3. ASIA PACIFIC
- 5.3.1. China
- 5.3.2. Japan
- 5.3.3. India
- 5.3.4. Korea
- 5.3.5. Rest of APAC
- 5.4. SOUTH AMERICA
- 5.4.1. Brazil
- 5.4.2. Rest of South America
- 5.5. REST OF THE WORLD
- 5.5.1. Middle East
- 5.5.2. Africa
- 5.6. GLOBAL DRUG ELUTING STENT MARKET REVENUE BY REGION, 2017-2025
- 5.6.1. Global Drug Eluting Stent Market Revenue (Million USD) and Share (%) By Region, 2017-2025
- 5.6.2. North America Market Revenue and Growth Rate, 2017-2025
- 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
- 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
- 5.6.5. South America Market Revenue and Growth Rate, 2017-2025
- 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025
CHAPTER 6. GLOBAL DRUG ELUTING STENT MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
- 6.1. GLOBAL DRUG ELUTING STENT MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
- 6.1.1. Global Drug Eluting Stent Market Production (Volume) and Share (%) By Region, 2017-2025
- 6.1.2. Global Drug Eluting Stent Market Consumption (Volume) and Share (%) By Region, 2017-2025
- 6.1.3. North America Market Production and Consumption, 2017-2025
- 6.1.4. Europe Market Production and Consumption, 2017-2025
- 6.1.5. Asia Pacific Market Production and Consumption, 2017-2025
- 6.1.6. South America Market Production and Consumption, 2017-2025
- 6.1.7. Rest of the World Market Production and Consumption, 2017-2025
CHAPTER 7. MARKET DETERMINANTS
- 7.1. MARKET DRIVERS
- 7.2. MARKET RESTRAINTS
- 7.3. MARKET OPPORTUNITIES
- 7.4. MARKET DETERMINANTS RADAR CHART
CHAPTER 8. GLOBAL DRUG ELUTING STENT MARKET COMPETITION BY MANUFACTURERS
- 8.1. GLOBAL DRUG ELUTING STENT PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
- 8.1.1. Global Drug Eluting Stent Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
- 8.2. GLOBAL DRUG ELUTING STENT REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
- 8.2.1. Global Drug Eluting Stent Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
- 8.3. DRUG ELUTING STENT MARKET COMPETITIVE SITUATION AND TRENDS
- 8.3.1. Drug Eluting Stent Market Share (%) of Top 3 Manufacturers
- 8.3.2. Drug Eluting Stent Market Share (%) of Top 5 Manufacturers
CHAPTER 9. GLOBAL DRUG ELUTING STENT MANUFACTURERS ANALYSIS
- 9.1. ABBOTT LABORATORIES
- 9.1.1. Business Overview
- 9.1.2. Company Basic Information
- 9.1.3. Drug Eluting Stent Product Details
- 9.1.4. Abbott Laboratories Drug Eluting Stent Production, Revenue and Gross Margin
- 9.2. MERIL LIFE SCIENCES PVT.
- 9.2.1. Business Overview
- 9.2.2. Company Basic Information
- 9.2.3. Drug Eluting Stent Product Details
- 9.2.4. Meril Life Sciences Pvt. Drug Eluting Stent Production, Revenue and Gross Margin
- 9.3. BOSTON SCIENTIFIC CORPORATION
- 9.3.1. Business Overview
- 9.3.2. Company Basic Information
- 9.3.3. Drug Eluting Stent Product Details
- 9.3.4. Boston Scientific Corporation Drug Eluting Stent Production, Revenue and Gross Margin
- 9.4. MEDTRONIC PLC.
- 9.4.1. Business Overview
- 9.4.2. Company Basic Information
- 9.4.3. Drug Eluting Stent Product Details
- 9.4.4. Medtronic plc. Drug Eluting Stent Production, Revenue and Gross Margin
- 9.5. BIOSENSORS INTERNATIONAL GROUP, LTD.
- 9.5.1. Business Overview
- 9.5.2. Company Basic Information
- 9.5.3. Drug Eluting Stent Product Details
- 9.5.4. Biosensors International Group, Ltd. Drug Eluting Stent Production, Revenue and Gross Margin
- 9.6. BIOTRONIK SE & CO. KG
- 9.6.1. Business Overview
- 9.6.2. Company Basic Information
- 9.6.3. Drug Eluting Stent Product Details
- 9.6.4. BIOTRONIK SE & Co. KG Drug Eluting Stent Production, Revenue and Gross Margin
- 9.7. B. BRAUN MELSUNGEN AG
- 9.7.1. Business Overview
- 9.7.2. Company Basic Information
- 9.7.3. Drug Eluting Stent Product Details
- 9.7.4. B. Braun Melsungen AG Drug Eluting Stent Production, Revenue and Gross Margin
- 9.8. MICROPORT SCIENTIFIC CORPORATION, LTD.
- 9.8.1. Business Overview
- 9.8.2. Company Basic Information
- 9.8.3. Drug Eluting Stent Product Details
- 9.8.4. MicroPort Scientific Corporation, Ltd. Drug Eluting Stent Production, Revenue and Gross Margin
- 9.9. TERUMO CORPORATION
- 9.9.1. Business Overview
- 9.9.2. Company Basic Information
- 9.9.3. Drug Eluting Stent Product Details
- 9.9.4. TERUMO CORPORATION Drug Eluting Stent Production, Revenue and Gross Margin
- 9.10. TRANSLUMINA GMBH
- 9.10.1. Business Overview
- 9.10.2. Company Basic Information
- 9.10.3. Drug Eluting Stent Product Details
- 9.10.4. Translumina GmbH Drug Eluting Stent Production, Revenue and Gross Margin
CHAPTER 10. DRUG ELUTING STENT MARKET VALUE CHAIN ANALYSIS
- 10.1. DRUG ELUTING STENT INDUSTRIAL CHAIN ANALYSIS
- 10.2. DRUG ELUTING STENT KEY RAW MATERIALS ANALYSIS
- 10.2.1. Key Raw Materials
- 10.2.2. Price Trend of Key Raw Materials
- 10.2.3. Key Suppliers of Raw Materials
- 10.3. CONSUMER ANALYSIS
- 10.3.1. Consumer 1
- 10.3.2. Consumer 2
- 10.3.3. Consumer 3
Summary:
Get latest Market Research Reports on Drug Eluting Stent . Industry analysis & Market Report on Drug Eluting Stent is a syndicated market report, published as Drug Eluting Stent Market By Polymer Type (Bio-absorbable, Durable), By Material Type (Stainless steel, Cobalt chromium), By End User (Ambulatory surgical centers, Clinics, Hospitals), By Application (Coronary artery disease, Peripheral artery disease), Industry Trends, Estimation & Forecast, 2017 - 2025. It is complete Research Study and Industry Analysis of Drug Eluting Stent market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
